COMPOUND PROFILE / SMALL MOLECULES
CMS121.
Research draftCMS121 is an experimental fisetin-derived small molecule investigated in neurodegeneration.
Research evidence and COA results do not establish suitability for use. This is educational information, not a dosing guide or personal medical advice.
Targeted source and identity review, not a systematic review or complete regulatory audit.
Overview
CMS121 is an experimental fisetin-derived small molecule investigated in neurodegeneration.
Mechanism
It affects lipid-metabolism and cellular stress pathways, including fatty acid synthase-related activity.
Human research
A published phase 1 healthy-volunteer study examines safety and pharmacokinetics; it does not establish dementia efficacy.
Preclinical & other research
Mouse models reported cognitive and inflammatory effects.
Safety & unknowns
Early exposure data cannot settle long-term safety in older patients or disease populations.
Regulatory status
Investigational; the earlier description of exclusively preclinical evidence is outdated.
Reported use & evidence
The supplied CMS121 profile and its cited sources are imported. Community experiences and laboratory evidence remain separate from these descriptions. Missing evidence is not a zero result.
Sources & references
Follow the cited records and registered research. Profiles remain research drafts.